eProtocol

LER G1 Review Pathways – Higher risk research, Lower risk research, Exempted research

Bellberry Limited
A

LER G1 Review Pathways – Higher risk research, Lower risk research, Exempted research

LER G1
LER F1.1.5
LER F1.1.9
LER F1.1.11
LER F1.1.13
LER F1.1.14
LER F1.1.15
LER F1.1.16
Review Pathways – Higher risk and Lower risk research
Post marketing studies
Multi-stage Phase 1 in healthy volunteers
Extension studies
Taking over ethical oversight checklist
Psychedelic Drug Study considerations
Cannabis Study considerations
Application for Lower Risk Review
Go back